Showing results (21-30 of 649) with videos related to
Sort By:
Pageof 65
Nature Cancer|February 6, 2026
METTL3-based epitranscriptomic editing screening identifies functional m6A sites in cancersXin Xu, Yujuan Wang, Helen Zhu, et al.Nature Cancer|January 29, 2026
Targeted inhibition of FBXL2 confers susceptibility of HER2-negative breast cancer to trastuzumab deruxtecanJing Xu, Jing Liu, Yang Liu, et al.Nature Cancer|March 18, 2025
A Gremlin 1-expressing splenic niche cell population restrains chronic myeloid leukemia by antagonizing the BMP pathwayJinming Wang, Penghui Xu, Zhongzhong Ji, et al.Nature Cancer|August 28, 2025
MIRO2-mediated mitochondrial transfer from cancer cells induces cancer-associated fibroblast differentiationMichael Cangkrama, Huan Liu, Xiaoyu Wu, et al.Nature Cancer|September 2, 2025
An MRI-pathology foundation model for noninvasive diagnosis and grading of prostate cancerLizhi Shao, Chao Liang, Ye Yan, et al.Nature Cancer|April 30, 2020
Crowdsourcing a crisis response for COVID-19 in oncologyAakash Desai, Jeremy Warner, Nicole Kuderer, et al.Nature Cancer|February 29, 2020
Immune-awakening revealed by peripheral T cell dynamics after one cycle of immunotherapySara Valpione, Elena Galvani, Joshua Tweedy, et al.Nature Cancer|July 26, 2021
Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumorsElise M Fiala, Gowtham Jayakumaran, Audrey Mauguen, et al.Nature Cancer|June 28, 2021
Resident and circulating memory T cells persist for years in melanoma patients with durable responses to immunotherapyJichang Han, Yanding Zhao, Keisuke Shirai, et al.Nature Cancer|June 28, 2021
A first-in-class Polymerase Theta Inhibitor selectively targets Homologous-Recombination-Deficient TumorsJia Zhou, Camille Gelot, Constantia Pantelidou, et al.Pageof 65